

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * chemical homeostasis within a tissue (GO:0048875) | 9.75699973 |
| 2 | pattern specification involved in kidney development (GO:0061004) | 6.99665981 |
| 3 | cellular response to nitric oxide (GO:0071732) | 5.69563461 |
| 4 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 5.15805529 |
| 5 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 5.11568321 |
| 6 | morphogenesis of an endothelium (GO:0003159) | 4.57471094 |
| 7 | endothelial tube morphogenesis (GO:0061154) | 4.57471094 |
| 8 | response to xenobiotic stimulus (GO:0009410) | 4.49525105 |
| 9 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.47871111 |
| 10 | response to nitric oxide (GO:0071731) | 4.38277965 |
| 11 | epithelial tube branching involved in lung morphogenesis (GO:0060441) | 4.29904187 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.17269732 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 4.17269732 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.17269732 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.17269732 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.17269732 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 4.17269732 |
| 18 | lung lobe morphogenesis (GO:0060463) | 4.11001567 |
| 19 | cellular response to reactive nitrogen species (GO:1902170) | 3.95952239 |
| 20 | regulation of endothelial cell differentiation (GO:0045601) | 3.84255682 |
| 21 | respiratory gaseous exchange (GO:0007585) | 3.81586060 |
| 22 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.65897867 |
| 23 | regulation of hippo signaling (GO:0035330) | 3.59614286 |
| 24 | negative regulation of interleukin-2 production (GO:0032703) | 3.52395837 |
| 25 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.49993592 |
| 26 | mesodermal cell differentiation (GO:0048333) | 3.44826050 |
| 27 | establishment of apical/basal cell polarity (GO:0035089) | 3.41203836 |
| 28 | macrophage chemotaxis (GO:0048246) | 3.37901166 |
| 29 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.33972571 |
| 30 | adherens junction assembly (GO:0034333) | 3.31404813 |
| 31 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.31210558 |
| 32 | adenine nucleotide transport (GO:0051503) | 3.31135644 |
| 33 | segment specification (GO:0007379) | 3.27988693 |
| 34 | cellular anion homeostasis (GO:0030002) | 3.26471841 |
| 35 | respiratory tube development (GO:0030323) | 3.23309163 |
| 36 | macrophage activation involved in immune response (GO:0002281) | 3.23117345 |
| 37 | negative regulation of type 2 immune response (GO:0002829) | 3.21700964 |
| 38 | response to peptidoglycan (GO:0032494) | 3.18401529 |
| 39 | response to laminar fluid shear stress (GO:0034616) | 3.16530913 |
| 40 | lung-associated mesenchyme development (GO:0060484) | 3.14443099 |
| 41 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.14369578 |
| 42 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.13287889 |
| 43 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 3.12428596 |
| 44 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.10990292 |
| 45 | embryonic foregut morphogenesis (GO:0048617) | 3.10783236 |
| 46 | sodium-independent organic anion transport (GO:0043252) | 3.09289267 |
| 47 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.07242410 |
| 48 | establishment of monopolar cell polarity (GO:0061162) | 3.05671646 |
| 49 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.05671646 |
| 50 | lateral sprouting from an epithelium (GO:0060601) | 3.04303018 |
| 51 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.01093679 |
| 52 | regulation of vasculogenesis (GO:2001212) | 2.97486049 |
| 53 | cell-substrate adherens junction assembly (GO:0007045) | 2.97148602 |
| 54 | focal adhesion assembly (GO:0048041) | 2.97148602 |
| 55 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.96856859 |
| 56 | axis elongation (GO:0003401) | 2.95892328 |
| 57 | RNA stabilization (GO:0043489) | 2.95823555 |
| 58 | mRNA stabilization (GO:0048255) | 2.95823555 |
| 59 | trivalent inorganic anion homeostasis (GO:0072506) | 2.95463165 |
| 60 | phosphate ion homeostasis (GO:0055062) | 2.95463165 |
| 61 | purine ribonucleotide transport (GO:0015868) | 2.93577259 |
| 62 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.91649850 |
| 63 | response to muramyl dipeptide (GO:0032495) | 2.90362409 |
| 64 | regulation of glomerular filtration (GO:0003093) | 2.89266338 |
| 65 | branch elongation of an epithelium (GO:0060602) | 2.89002290 |
| 66 | glial cell proliferation (GO:0014009) | 2.85620275 |
| 67 | embryonic process involved in female pregnancy (GO:0060136) | 2.84669877 |
| 68 | forebrain neuron differentiation (GO:0021879) | 2.83315138 |
| 69 | glomerular epithelial cell development (GO:0072310) | 2.82118538 |
| 70 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.80874691 |
| 71 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.80779384 |
| 72 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.76025195 |
| 73 | blood vessel maturation (GO:0001955) | 2.74051805 |
| 74 | activation of Rac GTPase activity (GO:0032863) | 2.72990279 |
| 75 | Leydig cell differentiation (GO:0033327) | 2.71022937 |
| 76 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.70967553 |
| 77 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.70320980 |
| 78 | negative regulation of cell killing (GO:0031342) | 2.70320980 |
| 79 | eye photoreceptor cell differentiation (GO:0001754) | 2.68378327 |
| 80 | photoreceptor cell differentiation (GO:0046530) | 2.68378327 |
| 81 | pituitary gland development (GO:0021983) | 2.68349198 |
| 82 | lung secretory cell differentiation (GO:0061140) | 2.67462426 |
| 83 | proximal/distal pattern formation (GO:0009954) | 2.66886928 |
| 84 | nuclear pore complex assembly (GO:0051292) | 2.66714816 |
| 85 | semaphorin-plexin signaling pathway (GO:0071526) | 2.66398438 |
| 86 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.65753046 |
| 87 | Golgi transport vesicle coating (GO:0048200) | 2.65525069 |
| 88 | COPI coating of Golgi vesicle (GO:0048205) | 2.65525069 |
| 89 | modulation by symbiont of host cellular process (GO:0044068) | 2.64919960 |
| 90 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.64379700 |
| 91 | protein retention in ER lumen (GO:0006621) | 2.63841630 |
| 92 | folic acid transport (GO:0015884) | 2.63309425 |
| 93 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.63212356 |
| 94 | response to host (GO:0075136) | 2.62478372 |
| 95 | response to host defenses (GO:0052200) | 2.62478372 |
| 96 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.62478372 |
| 97 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.58524817 |
| 98 | regulation of interleukin-13 production (GO:0032656) | 2.58246259 |
| 99 | stress fiber assembly (GO:0043149) | 2.57928844 |
| 100 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.56904535 |
| 101 | cerebral cortex neuron differentiation (GO:0021895) | 2.56677816 |
| 102 | positive regulation of chemokine secretion (GO:0090197) | 2.56576333 |
| 103 | positive thymic T cell selection (GO:0045059) | 2.56004312 |
| 104 | response to host immune response (GO:0052572) | 2.55916077 |
| 105 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.55916077 |
| 106 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.54740326 |
| 107 | postsynaptic membrane organization (GO:0001941) | 2.52134178 |
| 108 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.52073367 |
| 109 | glomerular visceral epithelial cell development (GO:0072015) | 2.51053067 |
| 110 | maternal placenta development (GO:0001893) | 2.50909306 |
| 111 | positive regulation of interferon-alpha production (GO:0032727) | 2.50550354 |
| 112 | NIK/NF-kappaB signaling (GO:0038061) | 2.50319791 |
| 113 | apoptotic process involved in morphogenesis (GO:0060561) | 2.50230164 |
| 114 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.50210407 |
| 115 | one-carbon compound transport (GO:0019755) | 2.49921229 |
| 116 | detection of other organism (GO:0098543) | 2.49323747 |
| 117 | polarized epithelial cell differentiation (GO:0030859) | 2.48629098 |
| 118 | developmental induction (GO:0031128) | 2.47973940 |
| 119 | mesenchymal cell proliferation (GO:0010463) | 2.47213218 |
| 120 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.46269458 |
| 121 | pentose-phosphate shunt (GO:0006098) | 2.46197070 |
| 122 | protein complex localization (GO:0031503) | 2.46112157 |
| 123 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.45761427 |
| 124 | cellular response to virus (GO:0098586) | 2.45340402 |
| 125 | endocardial cushion development (GO:0003197) | 2.45307305 |
| 126 | pinocytosis (GO:0006907) | 2.45298282 |
| 127 | purine nucleotide transport (GO:0015865) | 2.44339157 |
| 128 | pre-miRNA processing (GO:0031054) | 2.43851341 |
| 129 | histone H3-K36 demethylation (GO:0070544) | 2.43295656 |
| 130 | regulation of smooth muscle cell differentiation (GO:0051150) | 2.42984129 |
| 131 | detection of bacterium (GO:0016045) | 2.41996652 |
| 132 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.41875475 |
| 133 | sphingosine metabolic process (GO:0006670) | 2.41788453 |
| 134 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.41282452 |
| 135 | cell-cell signaling involved in cell fate commitment (GO:0045168) | 2.40975095 |
| 136 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.40786184 |
| 137 | regulation of early endosome to late endosome transport (GO:2000641) | 2.40599906 |
| 138 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.39412454 |
| 139 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.39412454 |
| 140 | lung alveolus development (GO:0048286) | 2.39053274 |
| 141 | phosphate ion transmembrane transport (GO:0035435) | 2.38652165 |
| 142 | regulation of chemokine secretion (GO:0090196) | 2.38501944 |
| 143 | folic acid metabolic process (GO:0046655) | 2.38141838 |
| 144 | cellular protein complex localization (GO:0034629) | 2.37177438 |
| 145 | endothelial cell differentiation (GO:0045446) | 2.37022955 |
| 146 | mannose metabolic process (GO:0006013) | 2.36973431 |
| 147 | trophectodermal cell differentiation (GO:0001829) | 2.36626876 |
| 148 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.36578415 |
| 149 | regulation of glial cell proliferation (GO:0060251) | 2.36034422 |
| 150 | regulation of gamma-delta T cell activation (GO:0046643) | 2.35877430 |
| 151 | negative regulation of fatty acid transport (GO:2000192) | 2.35445935 |
| 152 | virion attachment to host cell (GO:0019062) | 2.34812828 |
| 153 | adhesion of symbiont to host cell (GO:0044650) | 2.34812828 |
| 154 | cellular hyperosmotic response (GO:0071474) | 2.34607207 |
| 155 | hippo signaling (GO:0035329) | 2.34367661 |
| 156 | cell-substrate junction assembly (GO:0007044) | 2.33824758 |
| 157 | regulation of interferon-alpha production (GO:0032647) | 2.33242051 |
| 158 | cranial suture morphogenesis (GO:0060363) | 2.32809000 |
| 159 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.32281402 |
| 160 | gas transport (GO:0015669) | 2.32249826 |
| 161 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.31577898 |
| 162 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.31189083 |
| 163 | protein localization to endosome (GO:0036010) | 2.30984389 |
| 164 | heterochromatin organization (GO:0070828) | 2.30792101 |
| 165 | sodium ion homeostasis (GO:0055078) | 2.29948460 |
| 166 | regulation of response to osmotic stress (GO:0047484) | 2.29914045 |
| 167 | DNA unwinding involved in DNA replication (GO:0006268) | 2.28573439 |
| 168 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.28231216 |
| 169 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.28056674 |
| 170 | negative regulation of cell fate specification (GO:0009996) | 2.26765389 |
| 171 | lymphangiogenesis (GO:0001946) | 2.26729830 |
| 172 | regulation of type 2 immune response (GO:0002828) | 2.25585235 |
| 173 | response to vitamin A (GO:0033189) | 2.25073669 |
| 174 | thymic T cell selection (GO:0045061) | 2.24856176 |
| 175 | determination of adult lifespan (GO:0008340) | 2.23102401 |
| 176 | detection of molecule of bacterial origin (GO:0032490) | 2.21980081 |
| 177 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.21729285 |
| 178 | regulation of leukocyte degranulation (GO:0043300) | 2.21411939 |
| 179 | germinal center formation (GO:0002467) | 2.20641490 |
| 180 | response to interleukin-6 (GO:0070741) | 2.20428994 |
| 181 | activation of MAPKKK activity (GO:0000185) | 2.20408474 |
| 182 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253) | 2.19778832 |
| 183 | renal system process involved in regulation of blood volume (GO:0001977) | 2.18994780 |
| 184 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.18721346 |
| 185 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.18449152 |
| 186 | negative regulation of interleukin-12 production (GO:0032695) | 2.18387594 |
| 187 | negative regulation of T cell proliferation (GO:0042130) | 2.18163684 |
| 188 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.18123553 |
| 189 | negative regulation of telomerase activity (GO:0051974) | 2.17370775 |
| 190 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.17043503 |
| 191 | mesenchymal to epithelial transition (GO:0060231) | 2.16636734 |
| 192 | * surfactant homeostasis (GO:0043129) | 12.6981070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.43624654 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.69123933 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.41264221 |
| 4 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.35319416 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.34494270 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.30020397 |
| 7 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.91708342 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.76191813 |
| 9 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 2.72848270 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.68265559 |
| 11 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.51732263 |
| 12 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.29892785 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.25411229 |
| 14 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.16724166 |
| 15 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.16396757 |
| 16 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.15997451 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.15225312 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.09079900 |
| 19 | KDM2B_26808549_Chip-Seq_K562_Human | 2.03949330 |
| 20 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.98633980 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.86400597 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.81127268 |
| 23 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.78946438 |
| 24 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.75531738 |
| 25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.75188488 |
| 26 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.73964898 |
| 27 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.71039987 |
| 28 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.70873484 |
| 29 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.68593952 |
| 30 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68120012 |
| 31 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.65548746 |
| 32 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.62390225 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62322724 |
| 34 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.59043047 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.58296137 |
| 36 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.57712451 |
| 37 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.57642076 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57049402 |
| 39 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56959306 |
| 40 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.56911762 |
| 41 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.56911762 |
| 42 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.56911762 |
| 43 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.55855329 |
| 44 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.54709146 |
| 45 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.54565711 |
| 46 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.53226133 |
| 47 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.52587561 |
| 48 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.52520924 |
| 49 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.46724819 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.46661264 |
| 51 | MYC_22102868_ChIP-Seq_BL_Human | 1.46323571 |
| 52 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.46294630 |
| 53 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46177130 |
| 54 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.45554443 |
| 55 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.45248458 |
| 56 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.44791404 |
| 57 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.43809118 |
| 58 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.43151230 |
| 59 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.43067244 |
| 60 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.42080485 |
| 61 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40718891 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.40634229 |
| 63 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40477640 |
| 64 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.40263313 |
| 65 | UTX_26944678_Chip-Seq_JUKART_Human | 1.39219671 |
| 66 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.38887481 |
| 67 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38371074 |
| 68 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.35753240 |
| 69 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34987700 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.34876345 |
| 71 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.34229234 |
| 72 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.33980552 |
| 73 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.33871405 |
| 74 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.33209923 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.32075501 |
| 76 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.31426935 |
| 77 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30879924 |
| 78 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30006135 |
| 79 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.29648956 |
| 80 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.29409360 |
| 81 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28530333 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27976162 |
| 83 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.27708308 |
| 84 | MAF_26560356_Chip-Seq_TH2_Human | 1.27364123 |
| 85 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27153324 |
| 86 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.26734808 |
| 87 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.22974575 |
| 88 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22209958 |
| 89 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.22141445 |
| 90 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.21881732 |
| 91 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.21694897 |
| 92 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.20667548 |
| 93 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19657171 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19446070 |
| 95 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.19442929 |
| 96 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18856704 |
| 97 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.18058953 |
| 98 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18005060 |
| 99 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17025486 |
| 100 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.14438749 |
| 101 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.13600587 |
| 102 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.12819443 |
| 103 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.11530496 |
| 104 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.10151982 |
| 105 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.10025369 |
| 106 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.09028333 |
| 107 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.08545067 |
| 108 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.08537308 |
| 109 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07260766 |
| 110 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07149875 |
| 111 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06282712 |
| 112 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05820373 |
| 113 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.05499633 |
| 114 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05311880 |
| 115 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04907455 |
| 116 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.03597258 |
| 117 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.02754868 |
| 118 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02344039 |
| 119 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.01825845 |
| 120 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01805558 |
| 121 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01770892 |
| 122 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01250034 |
| 123 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.00899062 |
| 124 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00565935 |
| 125 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.00540332 |
| 126 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00456058 |
| 127 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00339673 |
| 128 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.00171811 |
| 129 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99275569 |
| 130 | * P68_20966046_ChIP-Seq_HELA_Human | 0.99063718 |
| 131 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.98570296 |
| 132 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.98542496 |
| 133 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.97744105 |
| 134 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.97061172 |
| 135 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.97017689 |
| 136 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96966072 |
| 137 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95489225 |
| 138 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.95013326 |
| 139 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94610330 |
| 140 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.94437507 |
| 141 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94368431 |
| 142 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.93882847 |
| 143 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93592002 |
| 144 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93344335 |
| 145 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.92175068 |
| 146 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.91198496 |
| 147 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.89964619 |
| 148 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.89379303 |
| 149 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.89299910 |
| 150 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.88796894 |
| 151 | MAF_26560356_Chip-Seq_TH1_Human | 0.88488999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0004782_abnormal_surfactant_physiolog | 7.58721532 |
| 2 | MP0001958_emphysema | 5.18782063 |
| 3 | MP0008995_early_reproductive_senescence | 4.91155101 |
| 4 | MP0008004_abnormal_stomach_pH | 3.83826515 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.77534935 |
| 6 | MP0010368_abnormal_lymphatic_system | 2.85839825 |
| 7 | MP0000566_synostosis | 2.58893196 |
| 8 | MP0000537_abnormal_urethra_morphology | 2.41090520 |
| 9 | MP0003436_decreased_susceptibility_to | 2.33980461 |
| 10 | MP0005083_abnormal_biliary_tract | 2.33888956 |
| 11 | MP0009278_abnormal_bone_marrow | 2.33096705 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.12161525 |
| 13 | * MP0005388_respiratory_system_phenotype | 2.11213703 |
| 14 | * MP0002133_abnormal_respiratory_system | 2.11213703 |
| 15 | MP0001879_abnormal_lymphatic_vessel | 2.11145124 |
| 16 | MP0003453_abnormal_keratinocyte_physiol | 2.07667429 |
| 17 | MP0002254_reproductive_system_inflammat | 2.00472809 |
| 18 | MP0005451_abnormal_body_composition | 1.90428411 |
| 19 | MP0003890_abnormal_embryonic-extraembry | 1.81225199 |
| 20 | MP0000858_altered_metastatic_potential | 1.79369233 |
| 21 | * MP0001177_atelectasis | 1.78372570 |
| 22 | MP0003786_premature_aging | 1.73170106 |
| 23 | MP0004947_skin_inflammation | 1.72534980 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.70110223 |
| 25 | MP0003724_increased_susceptibility_to | 1.64950865 |
| 26 | MP0003115_abnormal_respiratory_system | 1.60024761 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.57416880 |
| 28 | MP0010030_abnormal_orbit_morphology | 1.57017972 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.56383267 |
| 30 | MP0004264_abnormal_extraembryonic_tissu | 1.56287631 |
| 31 | MP0003119_abnormal_digestive_system | 1.51578278 |
| 32 | MP0004272_abnormal_basement_membrane | 1.50397859 |
| 33 | MP0002419_abnormal_innate_immunity | 1.49630433 |
| 34 | MP0002277_abnormal_respiratory_mucosa | 1.41879402 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.41139269 |
| 36 | MP0005025_abnormal_response_to | 1.40807043 |
| 37 | MP0004233_abnormal_muscle_weight | 1.40139228 |
| 38 | * MP0001175_abnormal_lung_morphology | 1.39296496 |
| 39 | MP0005253_abnormal_eye_physiology | 1.37979651 |
| 40 | MP0000534_abnormal_ureter_morphology | 1.37662404 |
| 41 | MP0003763_abnormal_thymus_physiology | 1.37405467 |
| 42 | MP0002998_abnormal_bone_remodeling | 1.36593020 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.34175593 |
| 44 | MP0003950_abnormal_plasma_membrane | 1.33072070 |
| 45 | MP0002089_abnormal_postnatal_growth/wei | 1.29383584 |
| 46 | MP0002796_impaired_skin_barrier | 1.28999919 |
| 47 | MP0004808_abnormal_hematopoietic_stem | 1.28176781 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.27985803 |
| 49 | MP0001800_abnormal_humoral_immune | 1.27104378 |
| 50 | MP0002452_abnormal_antigen_presenting | 1.26382772 |
| 51 | * MP0005551_abnormal_eye_electrophysiolog | 1.24891454 |
| 52 | MP0002723_abnormal_immune_serum | 1.24867152 |
| 53 | MP0009672_abnormal_birth_weight | 1.24324386 |
| 54 | MP0005076_abnormal_cell_differentiation | 1.21420181 |
| 55 | MP0001819_abnormal_immune_cell | 1.20761132 |
| 56 | MP0002420_abnormal_adaptive_immunity | 1.20756440 |
| 57 | MP0006072_abnormal_retinal_apoptosis | 1.19081072 |
| 58 | MP0003111_abnormal_nucleus_morphology | 1.14454331 |
| 59 | MP0005621_abnormal_cell_physiology | 1.12937116 |
| 60 | MP0002398_abnormal_bone_marrow | 1.12044486 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.11118742 |
| 62 | MP0001348_abnormal_lacrimal_gland | 1.10414528 |
| 63 | MP0003303_peritoneal_inflammation | 1.10183340 |
| 64 | MP0003942_abnormal_urinary_system | 1.09684147 |
| 65 | MP0004858_abnormal_nervous_system | 1.09546473 |
| 66 | * MP0002295_abnormal_pulmonary_circulatio | 1.08177340 |
| 67 | MP0005257_abnormal_intraocular_pressure | 1.07095099 |
| 68 | MP0002166_altered_tumor_susceptibility | 1.06608758 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.05717885 |
| 70 | MP0002396_abnormal_hematopoietic_system | 1.05400518 |
| 71 | MP0001873_stomach_inflammation | 1.05381099 |
| 72 | MP0009840_abnormal_foam_cell | 1.04318722 |
| 73 | MP0001346_abnormal_lacrimal_gland | 1.04120946 |
| 74 | MP0000703_abnormal_thymus_morphology | 1.03953687 |
| 75 | MP0000716_abnormal_immune_system | 1.03180456 |
| 76 | MP0000516_abnormal_urinary_system | 1.02308699 |
| 77 | MP0005367_renal/urinary_system_phenotyp | 1.02308699 |
| 78 | MP0002405_respiratory_system_inflammati | 1.01433911 |
| 79 | MP0005623_abnormal_meninges_morphology | 1.00509787 |
| 80 | * MP0005195_abnormal_posterior_eye | 0.99563040 |
| 81 | MP0005671_abnormal_response_to | 0.99280635 |
| 82 | MP0010155_abnormal_intestine_physiology | 0.99164272 |
| 83 | MP0002282_abnormal_trachea_morphology | 0.99049306 |
| 84 | MP0002234_abnormal_pharynx_morphology | 0.98371119 |
| 85 | MP0003690_abnormal_glial_cell | 0.97973730 |
| 86 | MP0000767_abnormal_smooth_muscle | 0.97259123 |
| 87 | MP0010307_abnormal_tumor_latency | 0.97009445 |
| 88 | MP0010352_gastrointestinal_tract_polyps | 0.96742890 |
| 89 | MP0002925_abnormal_cardiovascular_devel | 0.96537644 |
| 90 | * MP0001943_abnormal_respiration | 0.96356884 |
| 91 | MP0000631_abnormal_neuroendocrine_gland | 0.94962925 |
| 92 | MP0002429_abnormal_blood_cell | 0.94855514 |
| 93 | MP0003984_embryonic_growth_retardation | 0.93823612 |
| 94 | MP0002722_abnormal_immune_system | 0.93643587 |
| 95 | MP0005391_vision/eye_phenotype | 0.92776175 |
| 96 | MP0001672_abnormal_embryogenesis/_devel | 0.92134171 |
| 97 | MP0005380_embryogenesis_phenotype | 0.92134171 |
| 98 | MP0001730_embryonic_growth_arrest | 0.91844383 |
| 99 | MP0003011_delayed_dark_adaptation | 0.91551489 |
| 100 | MP0004510_myositis | 0.91331148 |
| 101 | MP0006292_abnormal_olfactory_placode | 0.90596849 |
| 102 | MP0008260_abnormal_autophagy | 0.90521963 |
| 103 | MP0005409_darkened_coat_color | 0.90418333 |
| 104 | MP0000465_gastrointestinal_hemorrhage | 0.90290265 |
| 105 | MP0002098_abnormal_vibrissa_morphology | 0.89399800 |
| 106 | MP0002088_abnormal_embryonic_growth/wei | 0.88519040 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.87676475 |
| 108 | MP0001915_intracranial_hemorrhage | 0.87660885 |
| 109 | MP0006082_CNS_inflammation | 0.87105780 |
| 110 | MP0010234_abnormal_vibrissa_follicle | 0.85252133 |
| 111 | MP0002148_abnormal_hypersensitivity_rea | 0.85085634 |
| 112 | MP0004957_abnormal_blastocyst_morpholog | 0.84435193 |
| 113 | MP0002006_tumorigenesis | 0.84369753 |
| 114 | MP0002132_abnormal_respiratory_system | 0.84111052 |
| 115 | MP0001849_ear_inflammation | 0.83236066 |
| 116 | MP0003566_abnormal_cell_adhesion | 0.83164456 |
| 117 | MP0005397_hematopoietic_system_phenotyp | 0.83077560 |
| 118 | MP0001545_abnormal_hematopoietic_system | 0.83077560 |
| 119 | MP0003075_altered_response_to | 0.82362821 |
| 120 | MP0000685_abnormal_immune_system | 0.82206481 |
| 121 | MP0001293_anophthalmia | 0.82201249 |
| 122 | MP0004883_abnormal_blood_vessel | 0.81867169 |
| 123 | MP0002697_abnormal_eye_size | 0.81564770 |
| 124 | MP0003091_abnormal_cell_migration | 0.81368075 |
| 125 | MP0002085_abnormal_embryonic_tissue | 0.80379467 |
| 126 | MP0005501_abnormal_skin_physiology | 0.80175363 |
| 127 | MP0000678_abnormal_parathyroid_gland | 0.80087294 |
| 128 | MP0003191_abnormal_cellular_cholesterol | 0.79846811 |
| 129 | MP0001853_heart_inflammation | 0.79811726 |
| 130 | MP0000350_abnormal_cell_proliferation | 0.76844156 |
| 131 | MP0001851_eye_inflammation | 0.75405364 |
| 132 | MP0002084_abnormal_developmental_patter | 0.73645552 |
| 133 | MP0002653_abnormal_ependyma_morphology | 0.72940182 |
| 134 | MP0000462_abnormal_digestive_system | 0.72770020 |
| 135 | MP0003937_abnormal_limbs/digits/tail_de | 0.72753840 |
| 136 | MP0010678_abnormal_skin_adnexa | 0.72721735 |
| 137 | MP0001286_abnormal_eye_development | 0.71873443 |
| 138 | MP0003935_abnormal_craniofacial_develop | 0.70379156 |
| 139 | MP0003448_altered_tumor_morphology | 0.68195683 |
| 140 | MP0002086_abnormal_extraembryonic_tissu | 0.66673830 |
| 141 | MP0003693_abnormal_embryo_hatching | 0.65428611 |
| 142 | MP0004185_abnormal_adipocyte_glucose | 0.64679802 |
| 143 | MP0000428_abnormal_craniofacial_morphol | 0.63559923 |
| 144 | MP0000681_abnormal_thyroid_gland | 0.63526833 |
| 145 | MP0003077_abnormal_cell_cycle | 0.62649084 |
| 146 | MP0000383_abnormal_hair_follicle | 0.62639735 |
| 147 | * MP0001614_abnormal_blood_vessel | 0.62362681 |
| 148 | MP0002233_abnormal_nose_morphology | 0.61956675 |
| 149 | MP0000490_abnormal_crypts_of | 0.60594114 |
| 150 | MP0003943_abnormal_hepatobiliary_system | 0.59889177 |
| 151 | MP0008789_abnormal_olfactory_epithelium | 0.59061989 |
| 152 | MP0003123_paternal_imprinting | 0.58365427 |
| 153 | MP0005058_abnormal_lysosome_morphology | 0.58309414 |
| 154 | MP0002877_abnormal_melanocyte_morpholog | 0.57689891 |
| 155 | MP0000778_abnormal_nervous_system | 0.57256723 |
| 156 | MP0005023_abnormal_wound_healing | 0.57147753 |
| 157 | MP0006054_spinal_hemorrhage | 0.56039309 |
| 158 | MP0004197_abnormal_fetal_growth/weight/ | 0.55526161 |
| 159 | MP0000627_abnormal_mammary_gland | 0.55263478 |
| 160 | MP0005595_abnormal_vascular_smooth | 0.54839530 |
| 161 | MP0005187_abnormal_penis_morphology | 0.54594584 |
| 162 | MP0005387_immune_system_phenotype | 0.52418016 |
| 163 | MP0001790_abnormal_immune_system | 0.52418016 |
| 164 | MP0005394_taste/olfaction_phenotype | 0.52219167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Tachypnea (HP:0002789) | 4.93245858 |
| 2 | Tubulointerstitial fibrosis (HP:0005576) | 4.93075380 |
| 3 | Respiratory distress (HP:0002098) | 3.96658909 |
| 4 | Hyperactive renin-angiotensin system (HP:0000841) | 3.84201032 |
| 5 | Chronic bronchitis (HP:0004469) | 3.77321901 |
| 6 | Renal salt wasting (HP:0000127) | 3.76260170 |
| 7 | Hyperacusis (HP:0010780) | 3.60387009 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.36469351 |
| 9 | Abnormality of the fingertips (HP:0001211) | 3.29089153 |
| 10 | Onycholysis (HP:0001806) | 3.28378886 |
| 11 | Tubulointerstitial nephritis (HP:0001970) | 3.15706758 |
| 12 | Polycythemia (HP:0001901) | 3.10800216 |
| 13 | Thyroid-stimulating hormone excess (HP:0002925) | 3.08812205 |
| 14 | Ulnar bowing (HP:0003031) | 3.04493305 |
| 15 | Neurofibrillary tangles (HP:0002185) | 3.04312379 |
| 16 | Hematochezia (HP:0002573) | 3.02745211 |
| 17 | Tubulointerstitial abnormality (HP:0001969) | 2.89700443 |
| 18 | Congenital stationary night blindness (HP:0007642) | 2.78670362 |
| 19 | Stenosis of the external auditory canal (HP:0000402) | 2.76286184 |
| 20 | Megalencephaly (HP:0001355) | 2.65388938 |
| 21 | Supranuclear gaze palsy (HP:0000605) | 2.63558798 |
| 22 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.60085431 |
| 23 | Recurrent abscess formation (HP:0002722) | 2.57178485 |
| 24 | Asymmetry of the thorax (HP:0001555) | 2.54344232 |
| 25 | Chronic otitis media (HP:0000389) | 2.53091085 |
| 26 | Cerebral inclusion bodies (HP:0100314) | 2.51475370 |
| 27 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.45381029 |
| 28 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.45381029 |
| 29 | Single umbilical artery (HP:0001195) | 2.45381029 |
| 30 | Cellulitis (HP:0100658) | 2.39658721 |
| 31 | Stomach cancer (HP:0012126) | 2.35743444 |
| 32 | Tubular atrophy (HP:0000092) | 2.28929257 |
| 33 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.28735752 |
| 34 | Pendular nystagmus (HP:0012043) | 2.23338763 |
| 35 | Gout (HP:0001997) | 2.22754723 |
| 36 | Bowed forearm bones (HP:0003956) | 2.20873889 |
| 37 | Bowing of the arm (HP:0006488) | 2.20873889 |
| 38 | Hyperkalemia (HP:0002153) | 2.20245339 |
| 39 | Gastrointestinal stroma tumor (HP:0100723) | 2.20217483 |
| 40 | Posterior subcapsular cataract (HP:0007787) | 2.18324295 |
| 41 | Insomnia (HP:0100785) | 2.13375974 |
| 42 | Disproportionate tall stature (HP:0001519) | 2.11908069 |
| 43 | Broad distal phalanx of finger (HP:0009836) | 2.11698905 |
| 44 | Split foot (HP:0001839) | 2.11361739 |
| 45 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.11116035 |
| 46 | Neonatal respiratory distress (HP:0002643) | 2.10807110 |
| 47 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.10052101 |
| 48 | Arnold-Chiari malformation (HP:0002308) | 2.09359708 |
| 49 | Broad face (HP:0000283) | 2.08644271 |
| 50 | Partial duplication of thumb phalanx (HP:0009944) | 2.07582362 |
| 51 | Visceral angiomatosis (HP:0100761) | 2.07011792 |
| 52 | Recurrent bacterial skin infections (HP:0005406) | 2.04878095 |
| 53 | Hypotension (HP:0002615) | 2.03577205 |
| 54 | Elfin facies (HP:0004428) | 2.02135827 |
| 55 | Hemangiomatosis (HP:0007461) | 2.01560859 |
| 56 | Increased cerebral lipofuscin (HP:0011813) | 2.01344296 |
| 57 | Vertebral compression fractures (HP:0002953) | 2.00821045 |
| 58 | Interstitial pulmonary disease (HP:0006530) | 12.4072007 |
| 59 | Syringomyelia (HP:0003396) | 1.99056105 |
| 60 | Spinal cord lesions (HP:0100561) | 1.99056105 |
| 61 | Renal hypoplasia (HP:0000089) | 1.98795088 |
| 62 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.98756440 |
| 63 | Colitis (HP:0002583) | 1.96982826 |
| 64 | Cerebral aneurysm (HP:0004944) | 1.94110294 |
| 65 | Chorioretinal atrophy (HP:0000533) | 1.92811738 |
| 66 | Long palpebral fissure (HP:0000637) | 1.92557568 |
| 67 | Shallow orbits (HP:0000586) | 1.92332334 |
| 68 | Partial duplication of the phalanx of hand (HP:0009999) | 1.91831832 |
| 69 | Esophageal atresia (HP:0002032) | 1.89467915 |
| 70 | Overriding aorta (HP:0002623) | 1.88887065 |
| 71 | Selective tooth agenesis (HP:0001592) | 1.88060878 |
| 72 | Abnormality of the nasal mucosa (HP:0000433) | 1.87893430 |
| 73 | Protrusio acetabuli (HP:0003179) | 1.87659888 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.87498568 |
| 75 | Polygenic inheritance (HP:0010982) | 1.87056440 |
| 76 | Bronchitis (HP:0012387) | 1.86103031 |
| 77 | Abnormality of the labia minora (HP:0012880) | 1.85891513 |
| 78 | Shawl scrotum (HP:0000049) | 1.85286940 |
| 79 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.85202673 |
| 80 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.85202673 |
| 81 | Abnormality of glycolipid metabolism (HP:0010969) | 1.85202673 |
| 82 | Fragile nails (HP:0001808) | 1.84756500 |
| 83 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.84552010 |
| 84 | Metaphyseal cupping (HP:0003021) | 1.84369201 |
| 85 | Micronodular cirrhosis (HP:0001413) | 1.84054712 |
| 86 | Abnormality of the thoracic spine (HP:0100711) | 1.83301185 |
| 87 | Hemorrhage of the eye (HP:0011885) | 1.82120732 |
| 88 | Midline defect of the nose (HP:0004122) | 1.81948637 |
| 89 | Hyponatremia (HP:0002902) | 1.81391039 |
| 90 | Bronchomalacia (HP:0002780) | 1.80398055 |
| 91 | Broad metatarsal (HP:0001783) | 1.79236370 |
| 92 | Renal duplication (HP:0000075) | 1.78415349 |
| 93 | Turricephaly (HP:0000262) | 1.78377265 |
| 94 | Spontaneous hematomas (HP:0007420) | 1.77653302 |
| 95 | Osteolytic defects of the hand bones (HP:0009699) | 1.77369618 |
| 96 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.77369618 |
| 97 | Persistence of primary teeth (HP:0006335) | 1.77270620 |
| 98 | Thin bony cortex (HP:0002753) | 1.76579221 |
| 99 | Renovascular hypertension (HP:0100817) | 1.75893917 |
| 100 | Increased IgE level (HP:0003212) | 1.75338444 |
| 101 | Flat acetabular roof (HP:0003180) | 1.75030256 |
| 102 | Intestinal atresia (HP:0011100) | 1.74141217 |
| 103 | Anteriorly placed anus (HP:0001545) | 1.73463224 |
| 104 | Gingivitis (HP:0000230) | 1.72467680 |
| 105 | Neuronal loss in central nervous system (HP:0002529) | 1.72441280 |
| 106 | Subacute progressive viral hepatitis (HP:0006572) | 1.71167830 |
| 107 | Emphysema (HP:0002097) | 1.70965857 |
| 108 | Thickened helices (HP:0000391) | 1.70705203 |
| 109 | Mediastinal lymphadenopathy (HP:0100721) | 1.69783162 |
| 110 | Pigmentary retinal degeneration (HP:0001146) | 1.68667688 |
| 111 | Orchitis (HP:0100796) | 1.68385743 |
| 112 | Long toe (HP:0010511) | 1.67552629 |
| 113 | Aqueductal stenosis (HP:0002410) | 1.66773976 |
| 114 | Gastrointestinal atresia (HP:0002589) | 1.65945292 |
| 115 | Gastrointestinal infarctions (HP:0005244) | 1.65812963 |
| 116 | Progressive sensorineural hearing impairment (HP:0000408) | 1.65785040 |
| 117 | Ankyloglossia (HP:0010296) | 1.65626724 |
| 118 | Distal lower limb amyotrophy (HP:0008944) | 1.65566963 |
| 119 | Subcapsular cataract (HP:0000523) | 1.64725302 |
| 120 | Viral hepatitis (HP:0006562) | 1.64602605 |
| 121 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.64333178 |
| 122 | Achilles tendon contracture (HP:0001771) | 1.64109495 |
| 123 | Humeroradial synostosis (HP:0003041) | 1.62188853 |
| 124 | Synostosis involving the elbow (HP:0003938) | 1.62188853 |
| 125 | Patellar dislocation (HP:0002999) | 1.62055013 |
| 126 | Supernumerary nipples (HP:0002558) | 1.61317097 |
| 127 | Abnormality of oral frenula (HP:0000190) | 1.60491909 |
| 128 | Rapidly progressive (HP:0003678) | 1.60200340 |
| 129 | Gastrointestinal inflammation (HP:0004386) | 1.60123962 |
| 130 | Pathologic fracture (HP:0002756) | 1.59159530 |
| 131 | Restrictive lung disease (HP:0002091) | 1.58598206 |
| 132 | Meningitis (HP:0001287) | 1.58212277 |
| 133 | Abnormality of chloride homeostasis (HP:0011422) | 1.57424077 |
| 134 | Increased connective tissue (HP:0009025) | 1.57106309 |
| 135 | Microcytic anemia (HP:0001935) | 1.56775603 |
| 136 | Personality changes (HP:0000751) | 1.56659331 |
| 137 | Colon cancer (HP:0003003) | 1.56255196 |
| 138 | Germ cell neoplasia (HP:0100728) | 1.56089364 |
| 139 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.55663887 |
| 140 | Dysmetric saccades (HP:0000641) | 1.55643241 |
| 141 | Thoracic kyphosis (HP:0002942) | 1.55265402 |
| 142 | Long nose (HP:0003189) | 1.55166217 |
| 143 | Hyperaldosteronism (HP:0000859) | 1.55068189 |
| 144 | Deep venous thrombosis (HP:0002625) | 1.54875379 |
| 145 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.54642146 |
| 146 | Loss of speech (HP:0002371) | 1.54323535 |
| 147 | Pointed chin (HP:0000307) | 1.54265498 |
| 148 | Myocardial infarction (HP:0001658) | 1.53887841 |
| 149 | Arterial tortuosity (HP:0005116) | 1.53856723 |
| 150 | Cortical dysplasia (HP:0002539) | 1.53705002 |
| 151 | Myositis (HP:0100614) | 1.53303615 |
| 152 | Leiomyosarcoma (HP:0100243) | 1.52513625 |
| 153 | Uterine leiomyosarcoma (HP:0002891) | 1.52513625 |
| 154 | Abnormality of macrophages (HP:0004311) | 1.52447706 |
| 155 | Skull defect (HP:0001362) | 1.52426761 |
| 156 | Gastrointestinal carcinoma (HP:0002672) | 1.51808465 |
| 157 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.51808465 |
| 158 | Bone pain (HP:0002653) | 1.51738910 |
| 159 | Premature rupture of membranes (HP:0001788) | 1.50976397 |
| 160 | Premature skin wrinkling (HP:0100678) | 1.50666357 |
| 161 | Esophageal varix (HP:0002040) | 1.49412456 |
| 162 | Pulmonary hypertension (HP:0002092) | 1.49364419 |
| 163 | Dysostosis multiplex (HP:0000943) | 1.49303979 |
| 164 | Abnormality of sodium homeostasis (HP:0010931) | 1.49121030 |
| 165 | Distal lower limb muscle weakness (HP:0009053) | 1.48975303 |
| 166 | Rectal prolapse (HP:0002035) | 1.48681273 |
| 167 | Osteomyelitis (HP:0002754) | 1.48061028 |
| 168 | Slow saccadic eye movements (HP:0000514) | 1.47785856 |
| 169 | Lymphopenia (HP:0001888) | 1.47768348 |
| 170 | Abnormality of the 2nd finger (HP:0004100) | 1.47727905 |
| 171 | Abolished electroretinogram (ERG) (HP:0000550) | 1.45945768 |
| 172 | Pulmonary artery stenosis (HP:0004415) | 1.45690348 |
| 173 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.44507314 |
| 174 | Milia (HP:0001056) | 1.43765278 |
| 175 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.41648210 |
| 176 | Aplasia involving bones of the extremities (HP:0009825) | 1.40280531 |
| 177 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.40280531 |
| 178 | Aplasia of the phalanges of the hand (HP:0009802) | 1.40280531 |
| 179 | Hypoplasia of the ulna (HP:0003022) | 1.39796328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK24 | 5.25484000 |
| 2 | FGFR2 | 4.23820708 |
| 3 | SMG1 | 3.68974089 |
| 4 | TIE1 | 3.67461766 |
| 5 | LRRK2 | 3.56404406 |
| 6 | TGFBR2 | 3.47209133 |
| 7 | PRPF4B | 3.11130303 |
| 8 | ERN1 | 2.71717950 |
| 9 | IRAK3 | 2.71108435 |
| 10 | STK10 | 2.64109808 |
| 11 | GRK1 | 2.62608318 |
| 12 | PAK4 | 2.57246265 |
| 13 | FGFR4 | 2.48829709 |
| 14 | MAPK15 | 2.48596201 |
| 15 | EEF2K | 2.44663040 |
| 16 | ZAP70 | 2.43396156 |
| 17 | EPHB2 | 2.16344734 |
| 18 | SIK1 | 2.15820469 |
| 19 | RIPK4 | 2.10358098 |
| 20 | ILK | 2.05014411 |
| 21 | MAP3K9 | 1.96010527 |
| 22 | PDGFRB | 1.76191672 |
| 23 | IRAK4 | 1.75731291 |
| 24 | EPHA2 | 1.74800029 |
| 25 | CDK6 | 1.60747564 |
| 26 | MAP3K14 | 1.59267603 |
| 27 | TRIB3 | 1.51002620 |
| 28 | PKN2 | 1.50501258 |
| 29 | TTN | 1.50192766 |
| 30 | EPHB1 | 1.48123270 |
| 31 | MAP3K13 | 1.45632434 |
| 32 | TGFBR1 | 1.45031266 |
| 33 | MST1R | 1.32935524 |
| 34 | FGR | 1.30425721 |
| 35 | CLK1 | 1.25653441 |
| 36 | TAOK2 | 1.20173884 |
| 37 | LMTK2 | 1.19318077 |
| 38 | CAMK1D | 1.12736654 |
| 39 | RPS6KA4 | 1.12637779 |
| 40 | CDC42BPA | 1.10239675 |
| 41 | MTOR | 1.08243563 |
| 42 | RIPK1 | 1.06785402 |
| 43 | MAP2K3 | 1.06182942 |
| 44 | TAOK1 | 1.05749025 |
| 45 | GSK3A | 1.04308807 |
| 46 | TYK2 | 1.04225218 |
| 47 | MAP3K10 | 1.03652966 |
| 48 | CDK4 | 1.03383363 |
| 49 | TBK1 | 1.01779760 |
| 50 | RPS6KA2 | 1.00457981 |
| 51 | NME2 | 0.99847735 |
| 52 | DAPK2 | 0.99405829 |
| 53 | IRAK2 | 0.97579441 |
| 54 | BLK | 0.96372837 |
| 55 | CDK12 | 0.96011127 |
| 56 | HIPK2 | 0.93110346 |
| 57 | KSR2 | 0.92494175 |
| 58 | SIK3 | 0.90653197 |
| 59 | MST4 | 0.90359138 |
| 60 | TYRO3 | 0.89929493 |
| 61 | PDPK1 | 0.89827997 |
| 62 | YES1 | 0.88621923 |
| 63 | MAP3K8 | 0.87755745 |
| 64 | PDGFRA | 0.87549321 |
| 65 | AURKA | 0.87381383 |
| 66 | MELK | 0.84173026 |
| 67 | CSF1R | 0.83208207 |
| 68 | CHUK | 0.82730190 |
| 69 | VRK1 | 0.82304117 |
| 70 | BMX | 0.82031128 |
| 71 | MAP3K3 | 0.81768387 |
| 72 | EGFR | 0.81573264 |
| 73 | PTK6 | 0.80029165 |
| 74 | MAP3K1 | 0.78021158 |
| 75 | KDR | 0.76999493 |
| 76 | PRKD2 | 0.75817772 |
| 77 | JAK3 | 0.75753694 |
| 78 | RPS6KL1 | 0.72879853 |
| 79 | RPS6KC1 | 0.72879853 |
| 80 | MATK | 0.71769092 |
| 81 | DYRK1B | 0.71194465 |
| 82 | MAP2K2 | 0.70063867 |
| 83 | MKNK2 | 0.69489355 |
| 84 | DYRK2 | 0.69270018 |
| 85 | ERBB2 | 0.68559440 |
| 86 | NTRK1 | 0.67753423 |
| 87 | JAK1 | 0.67342122 |
| 88 | FER | 0.66926474 |
| 89 | MARK2 | 0.65599549 |
| 90 | TESK2 | 0.65582395 |
| 91 | MAP4K1 | 0.65103403 |
| 92 | MOS | 0.64923084 |
| 93 | BTK | 0.64894011 |
| 94 | CSK | 0.64152636 |
| 95 | DYRK3 | 0.63307365 |
| 96 | CAMK1G | 0.61352361 |
| 97 | MET | 0.61243326 |
| 98 | CHEK2 | 0.60755440 |
| 99 | NEK6 | 0.60402548 |
| 100 | EPHA3 | 0.60204080 |
| 101 | SCYL2 | 0.59303130 |
| 102 | ICK | 0.58847723 |
| 103 | CDC7 | 0.58611840 |
| 104 | FGFR1 | 0.57585105 |
| 105 | ARAF | 0.57288828 |
| 106 | IKBKE | 0.54369833 |
| 107 | HCK | 0.54318009 |
| 108 | CASK | 0.54205636 |
| 109 | MKNK1 | 0.53994563 |
| 110 | BRD4 | 0.53286281 |
| 111 | RPS6KA1 | 0.52932492 |
| 112 | IRAK1 | 0.52521182 |
| 113 | NEK2 | 0.51004113 |
| 114 | PDK1 | 0.50794631 |
| 115 | MAPK11 | 0.50623497 |
| 116 | FGFR3 | 0.49819167 |
| 117 | MARK1 | 0.49030732 |
| 118 | NEK9 | 0.48691348 |
| 119 | CDK8 | 0.48635825 |
| 120 | CSNK1G3 | 0.48227838 |
| 121 | RPS6KA6 | 0.47756908 |
| 122 | RET | 0.46913513 |
| 123 | LATS1 | 0.46525585 |
| 124 | CSNK1G1 | 0.45589539 |
| 125 | STK3 | 0.44574874 |
| 126 | PRKD1 | 0.44266940 |
| 127 | NLK | 0.43806247 |
| 128 | MAP3K11 | 0.43514238 |
| 129 | MAP3K2 | 0.41643556 |
| 130 | CSNK1G2 | 0.40710231 |
| 131 | RPS6KB2 | 0.40257108 |
| 132 | SGK3 | 0.38968226 |
| 133 | STK4 | 0.37924510 |
| 134 | TTK | 0.37242248 |
| 135 | SRPK1 | 0.36805438 |
| 136 | GRK6 | 0.34925565 |
| 137 | DYRK1A | 0.34683577 |
| 138 | CSNK1A1L | 0.33640611 |
| 139 | ACVR1B | 0.33502315 |
| 140 | PLK1 | 0.33395553 |
| 141 | ADRBK1 | 0.33274672 |
| 142 | MAPK13 | 0.33021474 |
| 143 | SIK2 | 0.32928356 |
| 144 | JAK2 | 0.32536593 |
| 145 | BRAF | 0.32285653 |
| 146 | ABL1 | 0.32250570 |
| 147 | PRKG2 | 0.31942235 |
| 148 | ERBB3 | 0.31749315 |
| 149 | LATS2 | 0.31480196 |
| 150 | PRKCI | 0.31232347 |
| 151 | CDK7 | 0.30758404 |
| 152 | ALK | 0.29759535 |
| 153 | PTK2 | 0.29349468 |
| 154 | PIM1 | 0.29296127 |
| 155 | RPS6KA5 | 0.29256434 |
| 156 | GRK5 | 0.29138461 |
| 157 | CDK9 | 0.28251493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 2.73438635 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.02125314 |
| 3 | Adherens junction_Homo sapiens_hsa04520 | 1.79225455 |
| 4 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.68697500 |
| 5 | Mineral absorption_Homo sapiens_hsa04978 | 1.65414889 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62947189 |
| 7 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.56055097 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.54714202 |
| 9 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.53287069 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52405384 |
| 11 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.47428749 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45742384 |
| 13 | Colorectal cancer_Homo sapiens_hsa05210 | 1.42578496 |
| 14 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.41499840 |
| 15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.40662536 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.35571052 |
| 17 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.32041132 |
| 18 | Endometrial cancer_Homo sapiens_hsa05213 | 1.31066073 |
| 19 | Tight junction_Homo sapiens_hsa04530 | 1.31059452 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.30333835 |
| 21 | Thyroid cancer_Homo sapiens_hsa05216 | 1.30237757 |
| 22 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.29278772 |
| 23 | Bladder cancer_Homo sapiens_hsa05219 | 1.27861237 |
| 24 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.22485972 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.21560874 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.20984261 |
| 27 | Lysosome_Homo sapiens_hsa04142 | 1.19460459 |
| 28 | Hepatitis B_Homo sapiens_hsa05161 | 1.19333131 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.18680722 |
| 30 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.17282295 |
| 31 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.16202926 |
| 32 | Axon guidance_Homo sapiens_hsa04360 | 1.14423333 |
| 33 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.13553860 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.12330823 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11430503 |
| 36 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.09494169 |
| 37 | Cell cycle_Homo sapiens_hsa04110 | 1.08496423 |
| 38 | Prion diseases_Homo sapiens_hsa05020 | 1.08244464 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.08118778 |
| 40 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.06227273 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.05732103 |
| 42 | Pathways in cancer_Homo sapiens_hsa05200 | 1.04352774 |
| 43 | DNA replication_Homo sapiens_hsa03030 | 1.03383216 |
| 44 | Focal adhesion_Homo sapiens_hsa04510 | 1.03187571 |
| 45 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.01583940 |
| 46 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.01571850 |
| 47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00409532 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 1.00229574 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99217289 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.98512811 |
| 51 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.97969886 |
| 52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.97604151 |
| 53 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.97190172 |
| 54 | Allograft rejection_Homo sapiens_hsa05330 | 0.96197034 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.94881663 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.94618715 |
| 57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93833683 |
| 58 | Ribosome_Homo sapiens_hsa03010 | 0.92898592 |
| 59 | Base excision repair_Homo sapiens_hsa03410 | 0.91864431 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91655369 |
| 61 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.91450808 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.89181727 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 0.88335293 |
| 64 | Malaria_Homo sapiens_hsa05144 | 0.86965719 |
| 65 | Spliceosome_Homo sapiens_hsa03040 | 0.86955627 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.86860437 |
| 67 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.86763780 |
| 68 | Apoptosis_Homo sapiens_hsa04210 | 0.86684471 |
| 69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.86504982 |
| 70 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.86210774 |
| 71 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.86100827 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85657373 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.84458357 |
| 74 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84265759 |
| 75 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.84232030 |
| 76 | Prostate cancer_Homo sapiens_hsa05215 | 0.84097367 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83977244 |
| 78 | Mismatch repair_Homo sapiens_hsa03430 | 0.82436543 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 0.79052515 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78584631 |
| 81 | Alcoholism_Homo sapiens_hsa05034 | 0.78320660 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76961398 |
| 83 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76685848 |
| 84 | Legionellosis_Homo sapiens_hsa05134 | 0.76463038 |
| 85 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76385993 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76371540 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.76104606 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.75777533 |
| 89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.75699744 |
| 90 | Glioma_Homo sapiens_hsa05214 | 0.75664906 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.75008835 |
| 92 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74871287 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74432036 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.73999479 |
| 95 | Melanoma_Homo sapiens_hsa05218 | 0.73982016 |
| 96 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.73981635 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73493878 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71345921 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.71102409 |
| 100 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.71097807 |
| 101 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.70999207 |
| 102 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70174036 |
| 103 | Shigellosis_Homo sapiens_hsa05131 | 0.69771888 |
| 104 | Gap junction_Homo sapiens_hsa04540 | 0.69348452 |
| 105 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.66919549 |
| 106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66723352 |
| 107 | Melanogenesis_Homo sapiens_hsa04916 | 0.66492602 |
| 108 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.65890249 |
| 109 | Olfactory transduction_Homo sapiens_hsa04740 | 0.65879261 |
| 110 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65746024 |
| 111 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.65658510 |
| 112 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.65567115 |
| 113 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64952297 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64670445 |
| 115 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.64571862 |
| 116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63049493 |
| 117 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62777187 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62319066 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62262828 |
| 120 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61519823 |
| 121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61417675 |
| 122 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.61371899 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60692742 |
| 124 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60507132 |
| 125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60346668 |
| 126 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60259472 |
| 127 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.59875941 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59172316 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58453498 |
| 130 | Pertussis_Homo sapiens_hsa05133 | 0.58328047 |
| 131 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.58102450 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | 0.57294141 |
| 133 | Insulin resistance_Homo sapiens_hsa04931 | 0.57221050 |
| 134 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56877142 |
| 135 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.56590497 |
| 136 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.56536377 |
| 137 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55555896 |
| 138 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55540067 |
| 139 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.55343304 |
| 140 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55307022 |
| 141 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54717951 |
| 142 | Hepatitis C_Homo sapiens_hsa05160 | 0.54596121 |
| 143 | RNA transport_Homo sapiens_hsa03013 | 0.53941178 |
| 144 | Taste transduction_Homo sapiens_hsa04742 | 0.53196208 |

